PubMed for Bookshelf ID: 4856138

Year	Number of Results
1973	1
1978	2
1981	1
1982	2
1984	1
1991	1
1993	1
1994	2
1995	1
1996	1
2003	1
2004	1
2006	1
2009	3
2011	1
2013	1
2014	1
2015	1
2024	0

1

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Serrano J; United States Drug Induced Liver Injury Network. Chalasani N, et al. Gastroenterology. 2015 Jun;148(7):1340-52.e7. doi: 10.1053/j.gastro.2015.03.006. Epub 2015 Mar 6. Gastroenterology. 2015. PMID: 25754159 Free PMC article.

2

Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial.

Joutsiniemi T, Timonen S, Leino R, Palo P, Ekblad U. Joutsiniemi T, et al. Arch Gynecol Obstet. 2014 Mar;289(3):541-7. doi: 10.1007/s00404-013-2995-5. Epub 2013 Aug 27. Arch Gynecol Obstet. 2014. PMID: 23978872 Clinical Trial.

3

Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicty in mice.

Song P, Zhang Y, Klaassen CD. Song P, et al. Toxicol Sci. 2011 Oct;123(2):359-67. doi: 10.1093/toxsci/kfr177. Epub 2011 Jul 11. Toxicol Sci. 2011. PMID: 21747115 Free PMC article.

4

Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy.

Gonzales E, Gerhardt MF, Fabre M, Setchell KD, Davit-Spraul A, Vincent I, Heubi JE, Bernard O, Jacquemin E. Gonzales E, et al. Gastroenterology. 2009 Oct;137(4):1310-1320.e1-3. doi: 10.1053/j.gastro.2009.07.043. Epub 2009 Jul 19. Gastroenterology. 2009. PMID: 19622360 Clinical Trial.

5

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.

Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Mooney J, Sargeant C, Braaten J, Bernard T, King D, Miceli E, Schmoll J, Hoskin T, Thapa P, Enders F. Lindor KD, et al. Hepatology. 2009 Sep;50(3):808-14. doi: 10.1002/hep.23082. Hepatology. 2009. PMID: 19585548 Free PMC article. Clinical Trial.

6

Bile acids: regulation of synthesis.

Chiang JY. Chiang JY. J Lipid Res. 2009 Oct;50(10):1955-66. doi: 10.1194/jlr.R900010-JLR200. Epub 2009 Apr 3. J Lipid Res. 2009. PMID: 19346330 Free PMC article. Review.

7

Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets.

Paumgartner G. Paumgartner G. World J Gastroenterol. 2006 Jul 28;12(28):4445-51. doi: 10.3748/wjg.v12.i28.4445. World J Gastroenterol. 2006. PMID: 16874853 Free PMC article. Review.

8

Bile acid synthetic defects and liver disease: a comprehensive review.

Bove KE, Heubi JE, Balistreri WF, Setchell KD. Bove KE, et al. Pediatr Dev Pathol. 2004 Jul-Aug;7(4):315-34. doi: 10.1007/s10024-002-1201-8. Epub 2004 Jul 15. Pediatr Dev Pathol. 2004. PMID: 15383928 Review.

9

Systematic review: ursodeoxycholic acid--adverse effects and drug interactions.

Hempfling W, Dilger K, Beuers U. Hempfling W, et al. Aliment Pharmacol Ther. 2003 Nov 15;18(10):963-72. doi: 10.1046/j.1365-2036.2003.01792.x. Aliment Pharmacol Ther. 2003. PMID: 14616161 Free article. Review.

10

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.

Colombo C, Battezzati PM, Podda M, Bettinardi N, Giunta A. Colombo C, et al. Hepatology. 1996 Jun;23(6):1484-90. doi: 10.1002/hep.510230627. Hepatology. 1996. PMID: 8675168 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year